4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Halozyme Therapeutics, Inc. (HALO) operates in the Biotechnology industry and is headquartered in San Diego, United States with about 423 employees. Its market capitalization is roughly $9 billion. In the fiscal year ended 2025-12-31, HALO reported $1.4B in revenue and $317M in net income.
Halozyme Therapeutics, Inc., a biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally.
Interactive charts & full statements → Open the HALO valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $1.4B | $1.0B | $829M | $660M | — |
| Gross Profit | $1.2B | $856M | $637M | $521M | — |
| Operating Income (EBIT) | $803M | $552M | $338M | $268M | — |
| Net Income | $317M | $444M | $282M | $202M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $377M | $452M | $354M | $326M | $265M | — |
| Gross Profit | $298M | $373M | $299M | $279M | $216M | — |
| Operating Income (EBIT) | $184M | $241M | $218M | $202M | $142M | — |
| Net Income | $150M | ($142M) | $175M | $165M | $118M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $2.5B | $2.1B | $1.7B | $1.8B | — |
| Total Liabilities | $2.5B | $1.7B | $1.6B | $1.7B | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive HALO viewer.
About TickerBase · Data methodology & sources